Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor‐associated antigens
The Prostate2004Vol. 63(3), pp. 252–258
Citations Over TimeTop 22% of 2004 papers
Fu‐Dong Shi, Jianying Zhang, Daorong Liu, Ann Rearden, Max L. Elliot, Dan Nachtsheim, Tracy R. Daniels‐Wells, Carlos A. Casiano, Mary J. Heeb, Edward K. L. Chan, Eng M. Tan
Abstract
A panel of six selected TAAs was shown to have high sensitivity and specificity as immunodiagnostic markers in prostate cancer.
Related Papers
- → Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis(2013)50 cited
- → Influence of Prostate Volume and Percent Free Prostate Specific Antigen on Prostate Cancer Detection in Men With a Total Prostate Specific Antigen of 2.6 to 10.0 ng/ml(2007)19 cited
- → Comparison of Percent Free Prostate Specific Antigen and Prostate Specific Antigen Density as Methods to Enhance Prostate Specific Antigen Specificity in Early Prostate Cancer Detection in Men With Normal Rectal Examination and Prostate Specific Antigen Between 4.1 and 10 ng./ml.(1997)4 cited
- → hTERT and DD3/PCA3 gene expression in prostatic tissues: differentiation between normal prostate, benign prostate hyperplasia and prostate tumours(2002)2 cited
- The value of serum total prostate-specific antigen, f/t value and PSAD in differentiating benign and malignant prostate diseases(2010)